Disc Medicine, Inc.

Disc Medicine, Inc. filed an 8-K with the Securities and Exchange Commission on August 14, 2020, under the ticker FSDC. The blank-check company was sponsored by Foresite Capital Management, a San Francisco-based investment firm with a concentrated focus on healthcare and life sciences opportunities. Foresite Capital positioned the vehicle to pursue a business combination within the biopharmaceutical and broader healthcare innovation space, sectors where the firm has deep domain expertise. The SPAC completed its initial public offering in 2020, a year that saw blank-check issuance reach historic levels across capital markets. For the full filing history, sponsor background, and deal analytics on FSDC, sign up for complete data access at SpacDesk.